Additionally, other eicosanoids such as protectins and resolvins may have shared effects with MaR1 on NAFLD, so this needs to be investigated to reflect the real relationship between MaR1 and NAFLD. Here, CD59 is linked to metabolic dysfunction-associated steatotic liver disease.